You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Geron Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for GERON, and what generic alternatives to GERON drugs are available?

GERON has one approved drug.

There are four US patents protecting GERON drugs.

There are one hundred and four patent family members on GERON drugs in thirty-three countries.

Summary for Geron
International Patents:104
US Patents:4
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Geron

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Geron RYTELO imetelstat sodium POWDER;INTRAVENOUS 217779-002 Jun 6, 2024 RX Yes Yes 9,388,415 ⤷  Sign Up ⤷  Sign Up
Geron RYTELO imetelstat sodium POWDER;INTRAVENOUS 217779-001 Jun 6, 2024 RX Yes Yes ⤷  Sign Up ⤷  Sign Up
Geron RYTELO imetelstat sodium POWDER;INTRAVENOUS 217779-002 Jun 6, 2024 RX Yes Yes 9,388,416 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Geron

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Geron RYTELO imetelstat sodium POWDER;INTRAVENOUS 217779-002 Jun 6, 2024 9,388,416 ⤷  Sign Up
Geron RYTELO imetelstat sodium POWDER;INTRAVENOUS 217779-001 Jun 6, 2024 9,388,415 ⤷  Sign Up
Geron RYTELO imetelstat sodium POWDER;INTRAVENOUS 217779-002 Jun 6, 2024 9,388,415 ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.